ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 534,05
0,08%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Provention Bio Inc (PRVB)

  7. Provention Bio Inc (PRVB) Actualités

PRVB

Provention Bio (PRVB)

Provention Bio Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PRVB
DateHeureSourceTitreSymboleSociété
08/05/202322h18Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:PRVBProvention Bio Inc
01/05/202312h20Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PRVBProvention Bio Inc
28/04/202322h21Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRVBProvention Bio Inc
28/04/202300h09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVBProvention Bio Inc
27/04/202323h01Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PRVBProvention Bio Inc
27/04/202322h49Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:PRVBProvention Bio Inc
27/04/202315h18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRVBProvention Bio Inc
27/04/202314h37Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:PRVBProvention Bio Inc
19/04/202323h11Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:PRVBProvention Bio Inc
29/03/202323h10Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PRVBProvention Bio Inc
24/03/202312h53Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:PRVBProvention Bio Inc
24/03/202312h11Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:PRVBProvention Bio Inc
24/03/202311h05Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:PRVBProvention Bio Inc
17/03/202321h17Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:PRVBProvention Bio Inc
13/03/202321h39Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:PRVBProvention Bio Inc
13/03/202312h00PR Newswire (US)Provention Bio Cancels Fourth Quarter and Full Year 2022 Earnings Release and Conference CallNASDAQ:PRVBProvention Bio Inc
03/03/202322h05PR Newswire (US)Provention Bio Announces the Grant of Inducement AwardsNASDAQ:PRVBProvention Bio Inc
23/02/202314h30PR Newswire (US)Provention Bio to Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023NASDAQ:PRVBProvention Bio Inc
13/02/202313h30PR Newswire (US)Provention Bio Announces Completion of $35 Million Equity Investment from Sanofi USNASDAQ:PRVBProvention Bio Inc
08/02/202313h30PR Newswire (US)Provention Bio to Present at the SVB Securities Global Biopharma ConferenceNASDAQ:PRVBProvention Bio Inc
02/02/202322h01PR Newswire (US)Provention Bio Announces Closing of Second Tranche with Hercules Capital to Support U.S. Commercial Launch of TZIELD®NASDAQ:PRVBProvention Bio Inc
05/01/202322h01PR Newswire (US)Provention Bio Announces Appointment of Rita Jain, M.D., to Board of DirectorsNASDAQ:PRVBProvention Bio Inc
21/11/202213h35TipRanksProvention Bio (PRVB) Receives a Buy from SVB SecuritiesNASDAQ:PRVBProvention Bio Inc
21/11/202205h15TipRanksSVB Securities Remains a Buy on Provention Bio (PRVB)NASDAQ:PRVBProvention Bio Inc
18/11/202223h55TipRanksChardan Capital Sticks to Their Buy Rating for Provention Bio (PRVB)NASDAQ:PRVBProvention Bio Inc
18/11/202211h09TipRanksProvention Bio (NASDAQ:PRVB) Stock Spikes as Diabetes Drug Gets FDA’s NodNASDAQ:PRVBProvention Bio Inc
18/11/202200h57Dow Jones NewsProvention Bio Up 8% on Diabetes Drug ApprovalNASDAQ:PRVBProvention Bio Inc
18/11/202200h39Dow Jones NewsProvention Bio Gets FDA OK for Diabetes DrugNASDAQ:PRVBProvention Bio Inc
17/11/202223h45PR Newswire (US)TZIELD™ (teplizumab-mzwv) approved by FDA as the first and only treatment indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adult and pediatric patients aged 8 years and older with Stage 2 T1DNASDAQ:PRVBProvention Bio Inc
07/11/202204h35TipRanksProvention Bio (PRVB) Gets a Buy from SVB SecuritiesNASDAQ:PRVBProvention Bio Inc
 Showing the most relevant articles for your search:NASDAQ:PRVB

Dernières Valeurs Consultées

COIN
BTCUSD
Bitcoin
EU
LR
Legrand
EU
VIV
Vivendi
EU
RNO
Renault
NASDAQ
AAPL
Apple
EU
AF
Air FranceKLM
EU
BNP
BNP Paribas
EU
SGO
Cie de SaintGobain
NASDAQ
MSFT
Microsoft
SPI
SP500
S&P 500
EU
VK
Vallourec
NASDAQ
AMZN
Amazon.com
EU
AI
Air Liquide
EU
MC
Lvmh Moet Hennessy Louis...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés